96912 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used Cytokine-induced proteins
DELIVERY OF CAS9 VIA ARRDC1-MEDIATED MICROVESICLES (ARMMS)
#2METHOD FOR PRODUCING MESENCHYMAL STEM CELLS
#3INTRACELLULAR GENOMIC TRANSPLANT AND METHODS OF THERAPY
#4MODULATION OF CANCER IMMUNITY WITH TYPE 2 INNATE LYMPHOID CELLS, INTERLEUKIN 33, AND/OR INTERFERON INDUCED PROTEIN 44
#5MODIFIED CELLS AND METHODS OF THERAPY
#6Delivery of CAS9 via ARRDC1-mediated microvesicles (ARMMs)
#7Modified cells and methods of therapy
#8Intracellular genomic transplant and methods of therapy
#9CANCER TREATMENT
#10Intracellular genomic transplant and methods of therapy
#11INTRACELLULAR GENOMIC TRANSPLANT AND METHODS OF THERAPY
#12Improved Loading of EVs with Therapeutic Proteins
#13Delivery of cargo proteins via ARRDC1-mediated microvesicles (ARMMs)
#14Intracellular genomic transplant and methods of therapy
#15Intracellular genomic transplant and methods of therapy
#16Intracellular genomic transplant and methods of therapy
#17Cancer treatment
#18Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
#19Delivery of cargo proteins via ARRDC1-mediated microvesicles (ARMMs)
#20Modulation of cancer immunity with type 2 innate lymphoid cells, interleukin 33, and/or interferon induced protein 44
#21Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
#22Methods of lowering serum cholesterol
#23Intracellular genomic transplant and methods of therapy
#24Modified cells and methods of therapy
#25Modified cells and methods of therapy
#26SOCS mimetics for the treatment of diseases
#27Animal model and method for studying gene-gene interactions
#28Delivery of CAS9 via ARRDC1-mediated microvesicles (ARMMs)
#29Amniotic membrane preparations and purified compositions and anti-inflammation methods
#30Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
#31Purified amniotic membrane compositions and methods of use
#32Cancer treatment
#33Method for treating cardiac infarction using HMGB1 fragment
#34Production of TSG-6 Protein
#35Production of a cysteine rich protein
#36Extracellular matrix heparin-binding domains
#37Amniotic membrane preparations and purified compositions and anti-inflammation methods
#38Polynucleotide for use in treatment of influenza A virus induced diseases, encoding modified Mx protein, said modified Mx protein, and a transgenic animal expressing gene encoding modified Mx protein
#39Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
#40Purified amniotic membrane compositions and methods of use
#41Amniotic membrane preparations and purified compositions and anti-inflammation methods
#42Purified amniotic membrane compositions and methods of use
#43Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
#44Biocompatible materials containing stable complexes of TSG-6 and hyaluronan and method of using same
#45Antibodies against HMGB1 and fragments thereof
#46Prokaryotic expression of soluble, active Dkk
#47Monoclonal antibodies against HMGB1
#48Human Dickkopf-related protein and nucleic acid molecules and uses therefor
#49Reversed mammalian protein-protein interaction trap
#50DKK-RELATED PROTEINS
#51ANTIBODIES THAT BIND DKK-RELATED PROTEINS
#52Methods of making antibodies specific for cysteine-rich soluble protein C23
#53Biocompatible materials containing stable complexes method of TSG-6 and hyaluronan and method of using same
#54Monoclonal antibodies against HMGB1
#55Novel human dickkopf-related protein and nucleic molecules and uses therefor
#56Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
#57Method for Producing Epidermal Growth Factor Using Fusion Proteins Comprising Fas-1 Domain
#58Monoclonal antibodies against HMGB1
#59Peptides and Derivatives Thereof Showing Cell Attachment, Spreading and Detachment Activity
#60Novel Splice Variants of Human Dkkl1
#61Amniotic membrane preparations and purified compositions and anti-inflammation methods
#62Antibodies to HTEEB42 protein
#63Purified amniotic membrane compositions and methods of use
#64Chemokine analogs for the treatment of human diseases
#65Human dickkopf-related protein and nucleic acid molecules and uses therefor
#66STAT3 decoy oligonucleotides and uses therefor
#67Interferon-alpha induced gene
#68Protein having PDZ domain sequence
#69Peptides and derivatives thereof showing cell attachment, spreading and detachment activity
#70Interferon-alpha induced genes
#71Human Dickkopf-related nucleic acid molecules
#72Interferon-alpha induced gene
#7328 human secreted proteins
#74Interferon alpha responsive protein
#75Monoclonal antibodies against HMGB1
#76Interferon-alpha induced gene
#77Antibodies that bind human Dickkopf-1 proteins